lobbying_activities: 3430551

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3430551	fa6b19f2-a9c4-48ac-b3d9-1d9406ffe4fb	Q3	TODD STRATEGY GROUP	401103321	GENENTECH, INC.	2025	third_quarter	PHA	Prescription drug payment reform. Supply chain. Strategic National Stockpile.	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office	60000		0	0	2025-10-12T13:40:13-04:00